RUNX2 and bone neoplasm: In addition, MBG/UCNPs significantly enhanced the early osteogenic differentiation of bone mesenchymal stem cells (BMSCs) in bone tumor defects through the activation of osteogenic markers ALP, Runt-related transcription factor 2 (Runx2), osteopontin, osteocalcin and bone salivary protein172.